Loss of imprinting of IGF2 correlates with hypomethylation of the H19 differentially methylated region in the tumor tissue of colorectal cancer patients

Molecular Medicine Reports

Volumn 5, Issue 6, 2012, Pages 1536-1540

  Tian, Fuliang ^a,b   Tang, Zhipeng ^b   Song, Guoqi ^c   Pan, Yuqin ^b   He, Bangshun ^b   Bao, Qian ^a   Wang, Shukui ^b  

^a NANJING NORMAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c NANTONG UNIVERSITY   (China)

Author keywords

Differentially methylated region; Imprinting; Insulin like growth factor 2; Methylation

Indexed keywords

GENOMIC DNA; SOMATOMEDIN B; TRANSCRIPTION FACTOR CTCF;

ADULT; AGED; ARTICLE; BINDING SITE; CANCER PATIENT; CANCER TISSUE; CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; FEMALE; GENOME IMPRINTING; HUMAN; HUMAN TISSUE; LOSS OF IMPRINTING; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; BINDING SITES; COLORECTAL NEOPLASMS; DNA METHYLATION; FEMALE; GENOTYPE; HETEROZYGOTE; HUMANS; INSULIN-LIKE GROWTH FACTOR II; MALE; MIDDLE AGED; PROMOTER REGIONS, GENETIC; RNA, UNTRANSLATED;

EID: 84860711163     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.833     Document Type: Article

References (32)

1. Kinzler KW and Vogelstein B: Lessons from hereditary colorectal cancer. Cell 87: 159-170, 1996. (Pubitemid 26358996)
2. Houlston RS, Collins A, Slack J and Morton NE: Dominant genes for colorectal cancer are not rare. Ann Hum Genet 56: 99-103, 1992.
3. Feinberg AP: Imprinting of a genomic domain of 11p15 and loss of imprinting in cancer: an introduction. Cancer Res 59: 1743-1746, 1999.
4. Bird A: DNA methylation patterns and epigenetic memory. Genes Dev 16: 6-21, 2002.
5. Jenuwein T and Allis CD: Translating the histone code. Science 293: 1074-1080, 2001. (Pubitemid 32758077)
6. Li E: Chromatin modification and epigenetic reprogramming in mammalian development. Nat Rev Genet 3: 662-673, 2002.
7. Kim HT, Choi BH, Niikawa N, Lee TS and Chang SI: Frequent loss of imprinting of the H19 and IGF-II genes in ovarian tumors. Am J Med Genet 80: 391-395, 1998. (Pubitemid 28541605)
8. Murphy SK, Huang Z, Wen Y, Spillman MA, Whitaker RS, Simel LR, Nichols TD, Marks JR and Berchuck A: Frequent IGF2/H19 domain epigenenic alterations and elevated IGF2 expression in epithelial ovarian cancer. Mol Cancer Res 4: 283-292, 2006.
9. Cui H, Onyango P, Brandenburg S, Wu Y, Hsieh CL and Feinberg AP: Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2. Cancer Res 62: 6442-6446, 2002. (Pubitemid 35364103)
10. Kondo M, Suzuki H, Ueda R, Osada H, Takagi K, Takahashi T, and Takahashi T: Frequent loss of imprinting of the H19 gene is often associated with its overexpression in human lung cancers. Oncogene 10: 1193-1198, 1995.
11. Takai D, Gonzales FA, Tsai YC, Thayer MJ and Jones PA: Large scale mapping of methylcytosines in CTCF-binding sites in the human H19 promoter and aberrant hypomethylation in human bladder cancer. Hum Mol Genet 10: 2619-2626, 2001. (Pubitemid 33133402)
12. Randhawa GS, Cui H, Barletta JA, Strichman-Almashanu LZ, Talpaz M, Kantarjian H, Deisseroth AB, Champlin RC and Feinberg AP: Loss of imprinting in disease progression in chronic myelogenous leukemia. Blood 91: 3144-3147, 1998. (Pubitemid 28193862)
13. Foulstone E, Prince S, Zaccheo O, Burns JL, Harper J, Jacobs C, Church D and Hassan AB: Insulin-like growth factor ligands, receptors, and binding proteins in cancer. J Pathol 205: 145-153, 2005. (Pubitemid 40227987)
14. Li X, Gray SG, Flam F, Pietsch T and Ekström TJ: Developmental-dependent DNA methylation of the IGF2 and H19 promoters is correlated to the promoter activities in human liver development. Int J Dev Biol 42: 687-693, 1998. (Pubitemid 28341947)
15. Toretsky JA and Helman LJ: Involvement of IGF-II in human cancer. J Endocrinol 149: 367-372, 1996. (Pubitemid 26196067)
16. Boissonnas CC, Abdalaoui HE, Haelewyn V, Fauque P, Dupont JM, Gut I, Vaiman D, Jouannet P, Tost J and Jammes H: Specific epigenetic alterations of IGF2-H19 locus in spermatozoa from infertile men. Eur J Hum Genet 18: 73-80, 2010.
17. Efstratiadis A: Parental imprinting of autosomal mammalian genes. Curr Opin Genet Dev 4: 265-280, 1994.
18. Constancia M, Kelsey GL and Reik W: Resourceful imprinting. Nature 432: 53-57, 2004. (Pubitemid 39490824)
19. Steinhoff C, Paulsen M, Kielbasa S, Walter J and Vingron M: Expression profile and transcription factor binding site exploration of imprinted genes in human and mouse. BMC Genomics 10: 144, 2009.
20. Engemann S, Strödicke M, Paulsen M, et al: Sequence and functional comparison in the Beckwith-Wiedemann region: implications for a novel imprinting centre and extended imprinting. Hum Mol Genet 9: 2691-2706, 2000.
21. Cui H, Horon IL, Ohlsson R, Hamilton SR and Feinberg AP: Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability. Nat Med 4: 1276-1280, 1998. (Pubitemid 28512108)
22. Yuji Takano, Goshi Shiota and Hironaka Kawasaki: Analysis of genomic imprinting of insulin-like growth factor 2 in colorectal cancer. Oncology 59: 210-216, 2000.
23. Kinouchi Y, Hiwatashi N, Higashioka S, Nagashima F, Chida M and Toyota T: Relaxation of imprinting of the insulin-like growth factor II gene in colorectal cancer. Cancer Lett 107: 105-108, 1996. (Pubitemid 26370864)
24. Cui H, Cruz-Correa M, Giardiello FM, et al: Loss of IGF2 imprinting: a potential marker of colorectal cancer risk. Science 299: 1753-1755, 2003. (Pubitemid 36337205)
25. Honda S, Arai Y, Haruta M, Sasaki F, Ohira M, Yamaoka H, Horie H, Nakagawara A, Hiyama E, Todo S and Kaneko Y: Loss of imprinting of IGF2 correlates with hypermethylation of the H19 differentially methylated region in hepatoblastoma. Br J Cancer 99: 1891-1899, 2008.
26. Ulaner GA, Vu TH, Li T, Hu JF, Yao XM, Yang Y, Gorlick R, Meyers P, Healey J, Ladanyi M and Hoffman AR: Loss of imprinting of IGF2 and H19 in osteosarcoma is accompanied by reciprocal methylation changes of a CTCF-binding site. Hum Mol Genet 12: 535-549, 2003. (Pubitemid 36305592)
27. Nakagawa H, Chadwick RB, Peltomaki P, Plass C, Nakamura Y, and de La Chapelle A: Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region of H19-associated CTCF-binding sites in colorectal cancer. Proc Natl Acad Sci USA 98: 591-596, 2001. (Pubitemid 32105087)
28. Leighton PA, Ingram RS, Eggenschwiler J, Efstratiadis A and Tilghman SM: Disruption of imprinting caused by deletion of the H19 gene region in mice. Nature 375: 34-39, 1995.
29. Ohlsson R, Renkawitz R and Lobanenkov V: CTCF is a uniquely versatile transcription regulator linked to epigenetics and disease. Trends Genet 17: 520-527, 2001. (Pubitemid 32763050)
30. Reik W and Murrell A: Genomic imprinting, silence across the border. Nature 405: 408-409, 2000. (Pubitemid 30367400)
31. Hark AT, Schoenherr CJ, Katz DJ, Ingram RS, Levorse JM and Tilghman SM: CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus. Nature 405: 486-489, 2000. (Pubitemid 30367428)
32. Bell AC and Felsenfeld G: Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene. Nature 405: 482-485, 2000. (Pubitemid 30367427)